Document is current
Any future updates will be listed below
-
Authors
Abdelrahman, Ahmed
Kumstel, Simone
Zhang, Xianbin
Liebig, Marie
Wendt, Edgar Heinz Uwe
Eichberg, Johanna
Palme, Rupert https://orcid.org/0000-0001-9466-3662
Thum, Thomas https://orcid.org/0000-0003-4360-1511
Vollmar, Brigitte
Zechner, Dietmar
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft
- License Information
-
More Information
Article History
Received: 13 March 2019
Accepted: 17 September 2019
First Online: 1 October 2019
Competing Interests
: T.T. filed and licensed patents about the use of miR-21 modulators for cardiovascular disease and fibrosis treatment. T.T. is founder and shareholder of Cardior Pharmaceuticals GmbH. All other authors declare no potential conflicts of interests.
